Peizhi Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peizhi Li has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Jian Ping Gong
Hokkaido University
7 shared publications Kun He
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, 74# Linjiang Road, Chongqing 400010, PR China
3 shared publicationsXiwen Zhu
Department of Anesthesiology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China
3 shared publicationsWenfeng Zhang
Department of Hepatobiliary Surgery, he Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China
2 shared publicationsChuan-Xin Wu
1 shared publicationChun Huang
1 shared publication
Latest Publications
- 1 February 2019
- Published by Elsevier in Molecular Immunology
- Vol. 106, 53-62
USP25 promotes endotoxin tolerance via suppressing K48-linked ubiquitination and degradation of TRAF3 in Kupffer cells
- 1 February 2019
- Published by Elsevier in Molecular Immunology
- Vol. 106, 53-62
USP25 promotes endotoxin tolerance via suppressing K48-linked ubiquitination and degradation of TRAF3 in Kupffer cells
- 7 August 2018
- Published by Wiley in Cell Proliferation
- Vol. 51 (6) , e12487
Cathepsin B regulates non‐canonical NLRP 3 inflammasome pathway by modulating activation of caspase‐11 in Kupffer cells
Objectives: The non‐canonical inflammasome pathway was described which engages caspase‐11 to mediate pyroptosis and the subsequent release of IL ‐1α, IL ‐1β and IL ‐18 in TLR 4‐independent way. Cathepsin B is capable of activating caspase‐11 under cell‐free conditions which may regulate non‐canonical NLRP 3 inflammasome pathway. In this study, we aimed to further investigate cathepsin B as potential activators of proinflammatory caspases which may be released upon proinflammatory stimuli and regulate non‐canonical NLRP 3 inflammasome pathway by modulating the activity of caspase‐11. Methods: Pharmacological and gene‐silencing approaches were used to evaluate the impact of cathepsin B on regulating non‐canonical NLRP 3 inflammasome pathway in wild‐type and TLR 4 –/– Kupffer cells. A sepsis model was also created to investigate the effect of cathepsin B on survival. Meanwhile, cathepsin B activity and the expression level of caspase‐4 were detected in human peripheral blood mononuclear cells ( PBMC ) which were separated from patients suffered from SIRS or sepsis and healthy volunteers. Results: LPS stimulation caused cathepsin B activity and caspase‐11 expression increase in TLR 4 –/– mice. Cathepsin B activity inhibition reduced the activation of caspase‐11 and inflammasome and benefited survival in TLR 4 –/– mice. Upregulation of cathepsin B activity and caspase‐4 activation was found in PBMC of patients with SIRS or sepsis. Conclusion: Our results suggest a critical role for cathepsin B as activators of proinflammatory caspases‐11 and the regulatory effect in LPS ‐induced caspases‐11‐dependent necrosis.
- 7 August 2018
- Published by Wiley in Cell Proliferation
- Vol. 51 (6) , e12487
Cathepsin B regulates non‐canonical NLRP 3 inflammasome pathway by modulating activation of caspase‐11 in Kupffer cells
Objectives: The non‐canonical inflammasome pathway was described which engages caspase‐11 to mediate pyroptosis and the subsequent release of IL ‐1α, IL ‐1β and IL ‐18 in TLR 4‐independent way. Cathepsin B is capable of activating caspase‐11 under cell‐free conditions which may regulate non‐canonical NLRP 3 inflammasome pathway. In this study, we aimed to further investigate cathepsin B as potential activators of proinflammatory caspases which may be released upon proinflammatory stimuli and regulate non‐canonical NLRP 3 inflammasome pathway by modulating the activity of caspase‐11. Methods: Pharmacological and gene‐silencing approaches were used to evaluate the impact of cathepsin B on regulating non‐canonical NLRP 3 inflammasome pathway in wild‐type and TLR 4 –/– Kupffer cells. A sepsis model was also created to investigate the effect of cathepsin B on survival. Meanwhile, cathepsin B activity and the expression level of caspase‐4 were detected in human peripheral blood mononuclear cells ( PBMC ) which were separated from patients suffered from SIRS or sepsis and healthy volunteers. Results: LPS stimulation caused cathepsin B activity and caspase‐11 expression increase in TLR 4 –/– mice. Cathepsin B activity inhibition reduced the activation of caspase‐11 and inflammasome and benefited survival in TLR 4 –/– mice. Upregulation of cathepsin B activity and caspase‐4 activation was found in PBMC of patients with SIRS or sepsis. Conclusion: Our results suggest a critical role for cathepsin B as activators of proinflammatory caspases‐11 and the regulatory effect in LPS ‐induced caspases‐11‐dependent necrosis.
- 28 July 2015
- Published by Bentham Science Publishers Ltd. in Current Signal Transduction Therapy
- Vol. 10 (1) , 63-72
Glucocorticoid-induced Tumor Necrosis Factor Receptor Ligand Aggravates Lipopolysaccharide-induced Inflammation by Down-regulating the Programmed Death Ligand in Kupffer Cells
Objective: To investigate the mechanism of GITRL on regulating the inflammatory reaction through the programmed death ligand (PDL1) in Kupffer cells (KCs). Methods: The KCs and the T cells were isolated and divided into 6 groups: (1) the Control group; (2) LPS group; (3) LPS+Control siRNA group, transfected with Control siRNA; (4) LPS+GITRL siRNA group, transfected with GITRL siRNA; (5) LPS+pEGFP-N1 control plasmid group, transfected with control plasmid; and (6) LPS+pEGFP-N1-GITRL plasmid group, transfected with GITRL plasmid. The control group was co-cultured in DMEM only, whereas all of the other groups were co-cultured with LPS (1 ug/m1). After 24 h of treatment, the expression levels of the TNF-α, GITRL, and PDL1 in the supernatant, proliferation and apoptosis of T cells and the transposition of P65 in KCs were evaluated. Results: The GITRL expression in KCs was obviously increased after LPS-stimulation in comparison to the control group. Concurrently, PDL1 was inhibited, the T cells proliferated, and TNF-α levels in the supernatant were obviously increased in the LPS group. With GITRL gene silencing, the restraint on PDL1 was clearly decreased, and the indexes of inflammation were not as obvious as in the LPS group. Furthermore, the results of the pEGFP-N1-GITRL group were opposite from that of the GITRL silencing group. However, the inflammation was exacerbated with the lower PDL1 expression. Conclusions: Increasing the expression of GITRL in the KCs may promote the proliferation of T cells by restraining PDL1, thus aggravating the inflammatory reaction. GITRL silencing could tilt the immunologic balance back and restraining the inflammatory reaction.
- 28 July 2015
- Published by Bentham Science Publishers Ltd. in Current Signal Transduction Therapy
- Vol. 10 (1) , 63-72
Glucocorticoid-induced Tumor Necrosis Factor Receptor Ligand Aggravates Lipopolysaccharide-induced Inflammation by Down-regulating the Programmed Death Ligand in Kupffer Cells
Objective: To investigate the mechanism of GITRL on regulating the inflammatory reaction through the programmed death ligand (PDL1) in Kupffer cells (KCs). Methods: The KCs and the T cells were isolated and divided into 6 groups: (1) the Control group; (2) LPS group; (3) LPS+Control siRNA group, transfected with Control siRNA; (4) LPS+GITRL siRNA group, transfected with GITRL siRNA; (5) LPS+pEGFP-N1 control plasmid group, transfected with control plasmid; and (6) LPS+pEGFP-N1-GITRL plasmid group, transfected with GITRL plasmid. The control group was co-cultured in DMEM only, whereas all of the other groups were co-cultured with LPS (1 ug/m1). After 24 h of treatment, the expression levels of the TNF-α, GITRL, and PDL1 in the supernatant, proliferation and apoptosis of T cells and the transposition of P65 in KCs were evaluated. Results: The GITRL expression in KCs was obviously increased after LPS-stimulation in comparison to the control group. Concurrently, PDL1 was inhibited, the T cells proliferated, and TNF-α levels in the supernatant were obviously increased in the LPS group. With GITRL gene silencing, the restraint on PDL1 was clearly decreased, and the indexes of inflammation were not as obvious as in the LPS group. Furthermore, the results of the pEGFP-N1-GITRL group were opposite from that of the GITRL silencing group. However, the inflammation was exacerbated with the lower PDL1 expression. Conclusions: Increasing the expression of GITRL in the KCs may promote the proliferation of T cells by restraining PDL1, thus aggravating the inflammatory reaction. GITRL silencing could tilt the immunologic balance back and restraining the inflammatory reaction.
- Open Access
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 23 (11)
Role of Kupffer cells in bacterial infectious diseases
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 23 (11)
Open AccessRole of Kupffer cells in bacterial infectious diseases
- 29 April 2014
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 10 (1) , 373-378
Effect of peroxisome proliferator-activated receptor γ on the cholesterol efflux of peritoneal macrophages in inflammation
Atherosclerosis, a chronic inflammatory disorder characterized by lipid and cholesterol accumulation, is the principal contributing factor to the pathology of cardiovascular disease. Macrophages contribute to plaque development by internalizing native and modified lipoproteins that convert them into cholesterol-rich foam cells. With multiple factors, including hypercholesterolemia and inflammation, promoting atherosclerosis, it is of great significance to elucidate how the mechanism of cholesterol efflux from the macrophages changes and the role of peroxisome proliferator-activated receptor γ (PPARγ) in these situations. Following isolation and culture of peritoneal macrophages from C57BL/6 mice in the present study, the cells were divided into three groups: The control group, the ciglitazone group and the PPARγ antisense oligonucleotide group. The expression of PPARγ and nuclear factor of κ light polypeptide gene enhancer in B‑cells inhibitor α (IκBα) in each group was observed through the levels of protein and mRNA, and then the cholesterol efflux of each group was investigated. In addition, the same experiments were repeated following stimulation of each group with lipopolysaccharide (LPS). No significant difference in the expression levels of PPARγ between the control group and ciglitazone group was observed. The expression levels of PPARγ in the PPARγ antisense oligonucleotide group were evidently lower than those in the control group. Subsequent to stimulation with LPS, the expression levels of PPARγ in the three groups were higher than those of each group prior to stimulation. The cholesterol efflux of the PPARγ antisense oligonucleotide group was clearly suppressed following stimulation with LPS in comparison with that of the other groups. PPARγ contributes to anti-inflammation by protecting IκBα from being phosphorylated and degraded and promoting cholesterol efflux from peritoneal macrophages in inflammation.
- 29 April 2014
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 10 (1) , 373-378
Effect of peroxisome proliferator-activated receptor γ on the cholesterol efflux of peritoneal macrophages in inflammation
Atherosclerosis, a chronic inflammatory disorder characterized by lipid and cholesterol accumulation, is the principal contributing factor to the pathology of cardiovascular disease. Macrophages contribute to plaque development by internalizing native and modified lipoproteins that convert them into cholesterol-rich foam cells. With multiple factors, including hypercholesterolemia and inflammation, promoting atherosclerosis, it is of great significance to elucidate how the mechanism of cholesterol efflux from the macrophages changes and the role of peroxisome proliferator-activated receptor γ (PPARγ) in these situations. Following isolation and culture of peritoneal macrophages from C57BL/6 mice in the present study, the cells were divided into three groups: The control group, the ciglitazone group and the PPARγ antisense oligonucleotide group. The expression of PPARγ and nuclear factor of κ light polypeptide gene enhancer in B‑cells inhibitor α (IκBα) in each group was observed through the levels of protein and mRNA, and then the cholesterol efflux of each group was investigated. In addition, the same experiments were repeated following stimulation of each group with lipopolysaccharide (LPS). No significant difference in the expression levels of PPARγ between the control group and ciglitazone group was observed. The expression levels of PPARγ in the PPARγ antisense oligonucleotide group were evidently lower than those in the control group. Subsequent to stimulation with LPS, the expression levels of PPARγ in the three groups were higher than those of each group prior to stimulation. The cholesterol efflux of the PPARγ antisense oligonucleotide group was clearly suppressed following stimulation with LPS in comparison with that of the other groups. PPARγ contributes to anti-inflammation by protecting IκBα from being phosphorylated and degraded and promoting cholesterol efflux from peritoneal macrophages in inflammation.
- 8 March 2014
- Published by Springer Nature in Hepatology International
- Vol. 8 (2) , 275-284
S-Adenosylmethionine attenuates lipopolysaccharide-induced liver injury by downregulating the Toll-like receptor 4 signal in Kupffer cells
Purpose S-Adenosylmethionine (SAM) is beneficial for lipopolysaccharide (LPS)-induced liver injury, but its molecular basis is not fully understood. The present study was carried out to investigate the effects of SAM on LPS signal transduction and its possible mechanism. Methods An animal model of LPS-induced liver injury was established by intraperitoneally injecting mice with 10 mg/kg LPS pretreatment with or without SAM (170 μmol/kg body weight). Toll-like receptor 4 (TLR4) protein expression in liver tissues and the tumor necrosis factor alpha (TNF-α) secretion level in serum were detected by immunohistochemistry and enzyme-linked immunosorbent assay, respectively. Then, Kupffer cells (KCs) were isolated and challenged with LPS, with or without SAM pretreatment (1,000 μM), and the expressions of TLR4 and myeloid differentiation primary response protein (MYD88) were assayed at the mRNA and protein levels. The activities of nuclear factor-kappa B (NF-κB) and p38 mitogen-activated protein kinase (MAPK) were also analyzed using Western blotting. Results SAM significantly improved the survival rate of endotoxemic mice (p < 0.05) and decreased TNF-α levels in serum (p < 0.05). Simultaneously, SAM also attenuated LPS-induced liver injury and expression of TLR4 and MYD88 in the hepatic sinusoid. Moreover, TLR4 and MYD88 gene and protein expressions were downregulated by SAM pretreatment in LPS-stimulated KCs. Finally, SAM did not affect NF-κB-p65 translocation into the nucleus (p > 0.05), but significantly inhibited p38 MAPK activation (p < 0.05). Conclusions SAM attenuated liver injury and improved the survival rate in endotoxemic mice by decreasing the TNF-α expression. The downregulative effect of SAM on TNF-α was mediated by suppressing activation of the TLR4/MAPK signaling pathway.
- 8 March 2014
- Published by Springer Nature in Hepatology International
- Vol. 8 (2) , 275-284
S-Adenosylmethionine attenuates lipopolysaccharide-induced liver injury by downregulating the Toll-like receptor 4 signal in Kupffer cells
Purpose S-Adenosylmethionine (SAM) is beneficial for lipopolysaccharide (LPS)-induced liver injury, but its molecular basis is not fully understood. The present study was carried out to investigate the effects of SAM on LPS signal transduction and its possible mechanism. Methods An animal model of LPS-induced liver injury was established by intraperitoneally injecting mice with 10 mg/kg LPS pretreatment with or without SAM (170 μmol/kg body weight). Toll-like receptor 4 (TLR4) protein expression in liver tissues and the tumor necrosis factor alpha (TNF-α) secretion level in serum were detected by immunohistochemistry and enzyme-linked immunosorbent assay, respectively. Then, Kupffer cells (KCs) were isolated and challenged with LPS, with or without SAM pretreatment (1,000 μM), and the expressions of TLR4 and myeloid differentiation primary response protein (MYD88) were assayed at the mRNA and protein levels. The activities of nuclear factor-kappa B (NF-κB) and p38 mitogen-activated protein kinase (MAPK) were also analyzed using Western blotting. Results SAM significantly improved the survival rate of endotoxemic mice (p < 0.05) and decreased TNF-α levels in serum (p < 0.05). Simultaneously, SAM also attenuated LPS-induced liver injury and expression of TLR4 and MYD88 in the hepatic sinusoid. Moreover, TLR4 and MYD88 gene and protein expressions were downregulated by SAM pretreatment in LPS-stimulated KCs. Finally, SAM did not affect NF-κB-p65 translocation into the nucleus (p > 0.05), but significantly inhibited p38 MAPK activation (p < 0.05). Conclusions SAM attenuated liver injury and improved the survival rate in endotoxemic mice by decreasing the TNF-α expression. The downregulative effect of SAM on TNF-α was mediated by suppressing activation of the TLR4/MAPK signaling pathway.
- 25 September 2012
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 58 (3) , 835-840
Radiofrequency-Assisted Versus Clamp-Crushing Parenchyma Transection in Cirrhotic Patients with Hepatocellular Carcinoma: A Randomized Clinical Trial
Surgical resection remains the optimal therapy for cirrhotic patients with hepatocellular carcinoma (HCC) that are not suitable for liver transplantation (LT). Recently, various innovative techniques for liver resection have been developed. The aim of the study was to compare radiofrequency-assisted parenchyma transection (RF-PT) with the traditional clamp-crushing (CC) technique to explore the preferred therapy in cirrhotic patients with HCC. From January 2009 to December 2010, 75 cirrhotic patients with HCC who underwent hepatectomy were randomized to RF-PT (group 1, n = 38) or CC-PT (group 2, n = 37) groups. The primary endpoint was intraoperative blood loss. The secondary endpoints included hepatic transection time, total operating time, postoperative morbidity, mortality, length of intensive care unit and hospital stays, and liver function. The characteristics of the two patient groups were closely matched. The Pringle maneuver was not used in RF-PT patients. The blood loss of the RF-PT group, total or during transection, was significantly lower than that of the CC-PT group (385 vs. 545 ml, p = 0.001; 105 vs. 260 ml, p = 0.000, respectively). Compared with CC-PT patients, the morbidity of the RF-PT group was lower though not statistically significant (28.9 vs. 38.8 %, p = 0.197). One death occurred in the RF-PT group 12 days postoperative due to a large area cerebral embolism. RF-PT is a safe and feasible surgical resection method for patients with cirrhosis and concomitant HCC. In addition, RF-PT results in lower blood loss and lower morbidity than the CC technique during liver resection.
- 25 September 2012
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 58 (3) , 835-840
Radiofrequency-Assisted Versus Clamp-Crushing Parenchyma Transection in Cirrhotic Patients with Hepatocellular Carcinoma: A Randomized Clinical Trial
Surgical resection remains the optimal therapy for cirrhotic patients with hepatocellular carcinoma (HCC) that are not suitable for liver transplantation (LT). Recently, various innovative techniques for liver resection have been developed. The aim of the study was to compare radiofrequency-assisted parenchyma transection (RF-PT) with the traditional clamp-crushing (CC) technique to explore the preferred therapy in cirrhotic patients with HCC. From January 2009 to December 2010, 75 cirrhotic patients with HCC who underwent hepatectomy were randomized to RF-PT (group 1, n = 38) or CC-PT (group 2, n = 37) groups. The primary endpoint was intraoperative blood loss. The secondary endpoints included hepatic transection time, total operating time, postoperative morbidity, mortality, length of intensive care unit and hospital stays, and liver function. The characteristics of the two patient groups were closely matched. The Pringle maneuver was not used in RF-PT patients. The blood loss of the RF-PT group, total or during transection, was significantly lower than that of the CC-PT group (385 vs. 545 ml, p = 0.001; 105 vs. 260 ml, p = 0.000, respectively). Compared with CC-PT patients, the morbidity of the RF-PT group was lower though not statistically significant (28.9 vs. 38.8 %, p = 0.197). One death occurred in the RF-PT group 12 days postoperative due to a large area cerebral embolism. RF-PT is a safe and feasible surgical resection method for patients with cirrhosis and concomitant HCC. In addition, RF-PT results in lower blood loss and lower morbidity than the CC technique during liver resection.
- 1 April 2011
- Vol. 42 (2) , 148-50
[The research progresses of effects of HMGB1 in the ischemia-reperfusion injury].
- 1 April 2011
- Vol. 42 (2) , 148-50
[The research progresses of effects of HMGB1 in the ischemia-reperfusion injury].